OFFICIAL PUBLICATION OF

by its subsidiary APPco

PSA launches new guide to naloxone supply

Megan Haggan 04/02/2016

sad man in front of graffitied wall: harm minimisation story

A new guide to inform pharmacists about the safe and effective supply of naloxone has been released by the PSA. The comprehensive guide has been produced following the TGA’s decision to broaden the scheduling of naloxone – a life-saving medicine used to for opioid overdose – to include a Schedule 3 listing. This means from

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

PSA launches new guide to naloxone supply

Previous Opioid use quadruples in Australia, but others can't access pain relief

Next Dental health resources for cancer patients

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Opioid use quadruples in Australia, but others can't access pain relief

Next Dental health resources for cancer patients

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.